Quantum BioPharma signs Phase 2 MS trial agreement
Quantum BioPharma (NASDAQ:QNTM) signed a study agreement with Thermo Fisher Scientific (NYSE:TMO) to implement its Phase 2 trial.
Quantum BioPharma (NASDAQ:QNTM) signed a study agreement with Thermo Fisher Scientific (NYSE:TMO) to implement its Phase 2 trial.
VinFast (NASDAQ:VFS) signed an initial partnership with NexMove to supply electric buses to United States customers by 2028.
Bluejay Diagnostics (NASDAQ:BJDX) released baseline data for its SYMON-II clinical validation study featuring 777 evaluable sepsis patients.
Telix Pharmaceuticals (NASDAQ:TLX) commenced U.S. distribution of its brain cancer imaging drug Pixclara with its first patient doses.
Surf Air Mobility (NYSE:SRFM) signed a definitive commercial agreement with Clipper Aviation to deploy its OperatorOS flight operations software.
Institutional digital asset exchange Bullish (NYSE:BLSH) reported total trading volume of $48.6 billion for September 2026.
Miami International Holdings (NYSE:MIAX) released its September 2026 trading volume metrics, highlighting sustained year-to-date expansion across its options execution venues.
Skydance (NYSE:SKYD), formerly Paramount Skydance, finalized its acquisition of Warner Bros. Discovery (NASDAQ:WBD) following the satisfaction of all regulatory approvals and closing conditions.
Tradeweb Markets (NASDAQ:TW) reported total trading volume of $81.6 trillion for September 2026 alongside an average daily volume of $3.7 trillion.
Uber Technologies (NYSE:UBER) entered into a definitive agreement to acquire workplace catering provider ezCater for $2.3 billion in cash.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy